Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Malaria vaccine results face scrutiny

A Correction to this article was published on 02 November 2011

Experts question early release of incomplete trial data.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. The RTS,S Clinical Trials Partnership New Engl. J. Med. (2011).

  2. Farlow, A. In The Science, Economics, and Politics of Malaria Vaccine Policy (2006). Chapter available at

  3. White, N. J. New Engl. J. Med. (2011).

  4. Moorthy, V. S., Reed, Z. & Smith, P. G. Vaccine 27, 624-628 (2009).

    Article  CAS  Google Scholar 

  5. World Health Organization et al. (2006). Available at

Download references


Related links

Related links

Related links in Nature Research

GAVI Alliance vastly exceeds US$3.7bn fundraising target

Pharma pledges to slash vaccine prices for developing world

Vaccines special

Related external links

Malaria Vaccine Initiative

Malaria Vaccine Technology Roadmap

Bill & Melinda Gates Foundation on malaria

GAVI Alliance

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butler, D. Malaria vaccine results face scrutiny. Nature 478, 439–440 (2011).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology